Renovos celebrates successes of 2024 and looks forward to the journey ahead
We have started the New Year on a good foot, thanks to some of the milestones and successes our team has achieved over 2024. We have expanded our technical
Renovos News
Renovos CSO, Emeritus Professor Richard Oreffo recognised with Biomaterials Advances Innovation Award
Our CSO, Emeritus Professor Richard Oreffo, has been awarded the 2024 Biomatierals Advances Innovation Award! The 2024 Biomaterials Advances Innovation Award is an award recognising innovative research in the biomaterials field
Renovos CSO, Emeritus Professor Richard Oreffo, appointed an Officer of the Order of the British Empire
Emeritus Professor Richard Oreffo, has been appointed an Officer of the Order of the British Empire in the King’s New Year’s Honours! The King’s New Year Honours celebrate those
Renovos wins Judges’ Picks in RESI London 2024
Renovos attended RESI London 2024, presented by Life Science Nation, in December. RESI, the Redefining Early Stage Investments conference series connects investors and start-ups across multiple domains, including life
Renovos wins second place for Innovator Award and Open-Mic competition at VentureFest South
Pitching and networking at VentureFest South 2024 Last Thursday, Renovos pitched our RENOVITE nanoclay drug delivery platform at VentureFest South, the event stimulating the innovation ecosystem in the South of
Renovos Biologics strengthens its Board’s US expertise with appointment of Lisa Ferrara
Lisa Ferrara, Ph.D., brings over 30 years of experience in orthopaedic medical device innovation and regulatory strategy in the USA Dr Ferrara will play a pivotal role in advancing Renovos’
Renovos Wins Best Technology in Spine Award 2024
Terrific news following a very busy summer at Renovos! We have won a BEST TECHNOLOGY IN SPINE award for 2024 / 2025 for RENOVITE® BMP-2, which will be presented during
Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE
Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® RENOVITE® BMP-2 is being developed as an alternative to bone graft materials for interbody spinal
Biocomposites invests in Renovos Biologics
Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform RENOVITE ® nanoclay is a novel therapeutic delivery platform for precision regenerative medicine Investment will help
Professor Richard Oreffo contributes to Bone series as guest editor
A new series of articles covering scaffolds and applications for bone regeneration and tissue engineering has been published in a Special Issue “VSI: Bone Regeneration” in the journal Bone with
Renovos wins Innovate UK’s Biomedical Catalyst funding!
Renovos has been awarded a £692,472 Biomedical Catalyst grant from Innovate UK, the UK’s innovation agency*. Innovate UK funds businesses to accelerate promising innovations towards commercially successful products, in specific
How Renovite nanoclays open up new opportunities in regenerative medicine
For anyone pioneering a new technology in regenerative medicine, it’s not long before you are asked what it is that sets your tech apart from the rapidly growing number of
Nanoclays and regenerative medicine: a journey towards the clinic
What role could clay play in the biomedical field and why is Renovos Biologics focussing on this industrial-type material for cutting edge regenerative medicine technologies? It is an interesting question,
Chemistry? Clays? Isn’t this a biologics company?
I’m a chemist working on clay for a biologics company. That may well sound like a juxtaposition. Add to that the fact that the biological application isn’t to do with
Renovos wins Innovate UK SMART grant
We are excited to announce that we have launched another project funded by Innovate UK! Renovos won funding via the highly competitive SMART competition run by Innovate UK, the UK’s
Renovos Biologics has appointed Patrick O’Donnell as Advisor to the Board
Patrick O’Donnell Previously a General Manager and Executive Vice-President of North America for BoneSupport A.B., CEO at Proteothera, Inc, Histogenics Corporation, Prochon-BioTech, and in commercial roles of escalating management responsibility
Three new nanoclay publications out this year!
Key read for nanoclays in drug delivery – group’s new publication on nanoclay in Nature Communications! The paper, which can be found here, reports on the use of bisphosphonate interactions
Renovos and its Nanoclay technology reviewed by Orthoworld
Renovos and our advanced nanoclay biomaterial, Renovite®, has been featured in Orthoworld. The article, “Renovos to Develop Next-Gen Technology to “Tame” BMP-2 Diffusion”, outlines key issues that novel regenerative medicine
Renovos receives investment for nanoclay innovation from leading medical research charity Orthopaedic Research UK
Renovos has recently been awarded one of the very first charity investments in the UK. In a progressive move to find new ways to support people living with painful and
Our nanoclay has been featured on the cover of Orthoworld’s Bonezone!
The synthetic nanoclay gel scaffold effectively localises new bone formation (in red). It offers injectable delivery and retention of biologics, released only to in-growing cells for efficacy at ultra-low doses
Innovation Challenge Finalist at RESI Boston
The Redefining Early Stage Investments (RESI) Conference took place on Wednesday 11th September 2019 in Boston. The organisers at Life Science Nation (LSN) invite all global early-stage companies across
Renovos and Caltag at BRS/BORS Cardiff
Working with Caltag Medsystems at BRS/BORS 2019 to spead the word about Renovos and our mesenchymal stem cell products. Together with Hannah from Caltag Medsystems, Renovos participated in Bone Research
Renovos Biologics has appointed Simon Sinclair as non-executive director
Simon Sinclair Previously in clinical trials at Merck & Co. Inc. and in medical affairs at DePuy Synthes and Johnson & Johnson, Simon is now working in safety and vigilance
Impact White Paper
Harnessing clay for regenerative medicine An Impact white paper Jon Dawson and Richard Oreffo have written a white paper on the nanoclay platform for Impact. In particular they share
Renovos at The Royal Society of Chemistry
On the 15th October Renovos took part in a Royal Society of Chemistry event called Chemistry means Business. This event is the flagship event for companies which are around Renovos’ size
Renovos Launches Innovate UK Grant!
We are excited to announce that we have launched our grant from Innovate UK! Innovate UK is a public body that aims to support the development of science and technology
Exhibiting technologies at Venturefest Oxford
Renovos showcased at VentureFest Oxford - a gateway for entrepreneurs and innovators to connect with investors and advisors
Showcasing our products to business giants at Canary Wharf
Renovos showcased to big name corporates including EDF Energy, Rolls-Royce and Samsung in Canary Wharf, London on 25 May 2017
Pitching for investment and showcasing technologies at Venturefest South
We showcased our innovative clay-gel technology used to aid the healing process of bone fractures at Venturefest South
Cocoon Networks China-UK Hi! Technology Festival
Renovos took part in the China-UK Hi! Technology Festival in November 2016 organised by Cocoon Networks an international startup ecosystem based in London
SetSquared Accelerating Growth Showcase
Renovos was among the high-growth tech entrepreneurs pitching for a share of more than £25m backing at the Showcase in London in November 2016.